Market cap
₹666 cr
Loading the extract…
Loading the extract…
Healthcare · Pharmaceuticals
INFLUX · NSE INFLUX
Market cap
₹666 cr
Price
288
52w high
315
52w low
141
PE
32.4
Industry PE
—
Book value
43.5
Dividend yield
0%
ROCE
40
ROE
30
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2026-03-31 |
|---|---|
| Depreciation | 4 |
| Dividend Payout % | 0 |
| EPS in Rs | 8.87 |
| Expenses | 117 |
| Interest | 0 |
| Net Profit | 21 |
| OPM % | 20 |
| Operating Profit | 30 |
| Other Income | 1 |
| Profit before tax | 27 |
| Sales | 147 |
| Tax % | 25 |
| Line | 2026-03-31 | 2025-09-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Depreciation | 2 | 2 | 2 | 1 |
| EPS in Rs | 4.56 | 4.32 | 4.21 | 3.1 |
| Expenses | 65 | 52 | 45 | 39 |
| Interest | 0 | 0 | 0 | 0 |
| Net Profit | 11 | 10 | 8 | 6 |
| OPM % | 19 | 22 | 20 | 19 |
| Operating Profit | 15 |
| Line | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| DIIs | 5.65 | 6.83 | 10.46 |
| FIIs | 0.16 | 1.83 | 3.38 |
| Promoters | 73.53 | 73.53 | 73.53 |
| Public | 20.66 | 17.8 | 12.62 |
| 15 |
| 11 |
| 9 |
| Other Income | 1 | 0 | 0 | 0 |
| Profit before tax | 14 | 13 | 10 | 8 |
| Raw PDF | — | — | — | — |
| Sales | 80 | 67 | 57 | 48 |
| Tax % | 25 | 23 | 24 | 27 |